Effect of arsenic trioxide in blocking the cell cycle of human prostate carcinoma PC-3 cells

Xin-min Ding,Ting-yi Bao,Zeng-yue Yang,Jian-xin Qiu,Sheng-chan Ju

DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.02.076

2005-01-01

Abstract:Aim: To investigate the effects of arsenic trioxide (As 2O 3) in inhibiting the growth of human prostate cancer(PCA) PC-3 cells and blocking the cell cycle of PCA PC-3 cells. Methods: The experiment was completed in the central laboratory of Tangdu Hospital, Fourth Military Medical University of Chinese PLA from October 2003 to May 2004. The trial for the inhibition of cell growth in vitro (MTT colorimetry) was conducted to study the effect of As 2O 3 on the growth of cells. Then, flow cytometric analysis was performed to assay the distribution of cell cycle. Western blotting was performed to investigate the changes of cyclin dependent kinases(CDKs), cyclin dependent kinase inhibitors (CDKIs) and cyclin. Results: A significant dose- and time-dependent growth inhibition was observed in As 2O 3-treated cells. From the results of MTT assay, the absorbance was significantly different among the groups after treated with As 2O 3 at 1, 2 and 5 μmol/L for 1 to 6 days (F = 22.220, P < 0.001). As shown in the assessment of cell cycle by flow cytometry, the gathering cells at G1 phase were increased [(51.8 ± 2.4)% to (58.8 ± 2.3)%] with the concentration of As 2O 3 (1, 2 and 5 μmol/L) at 72 hours after treatment, and there were significant, differences among the groups(χ 2 = 15.846, P = 0.01), indicating that As 2O 3 can block the PC-3 cells at G1 phase. As 2O 3 strongly increased the expression of PC-3 CDKIs, Cip1/p21 and Kip1/p27, in a dose-dependent manner, as well as downregulated CDK2, 6 and cyclin E, A. Conclusion: As 2O 3 inhibits cell cycle progression of human PAC PC-3 cells and inhibits their growth, so it needs more study to provide a basis for the application of As 2O 3 in the treatment of PCA.